文献速递慢性静脉疾病静脉血栓栓塞

下肢血栓后综合征腔内治疗四年结局

Four-year outcomes following endovascular treatment in patients with post-thrombotic syndrome of the lower extremities.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2025-05-14

本研究纳入115例下肢血栓后综合征(PTS)患者,评估腔内治疗的安全性和有效性并分析支架内再狭窄的危险因素。中位随访48个月,4年一期通畅率为65.3%±4.6%,术后1年Venous Clinical Severity Score和Villalta评分较术前显著下降,CEAP分级C5或C6与支架再狭窄相关(HR 2.24)。

要点

  • 4年一期通畅率为65.3%±4.6%,长期通畅率良好。
  • 术后1年静脉临床严重程度评分较术前降低7.0(95%CI 6.0-8.0,P<.001)。
  • CEAP分级C5或C6是支架内再狭窄的危险因素(HR 2.24)。

核心结论

  • 腔内治疗对下肢PTS安全有效,长期通畅率良好。
  • CEAP分级C5或C6被确定为支架内再狭窄的危险因素。

研究设计与样本

  • 单中心研究,纳入2016年5月至2022年4月接受腔内治疗的PTS患者115例。
  • 中位随访48个月(范围24-65个月)。

主要发现

  • 3个月、6个月、1年、2年、3年、4年一期通畅率分别为92.2%±2.5%、88.7%±3.0%、81.7%±3.6%、73.9%±4.1%、66.6%±4.5%、65.3%±4.6%。
  • 38例患者观察到支架内再狭窄。
  • 术后1年Venous Clinical Severity Score较术前降低7.0(95%CI 6.0-8.0,P<.001)。
  • 术后1年Villalta评分较术前降低11.4(95%CI 9.4-13.5,P<.001)。
  • Cox回归显示CEAP分级C5或C6与支架内再狭窄相关(HR 2.24,95%CI 1.18-4.25,P=.014)。

临床怎么用

  • 腔内治疗可用于下肢PTS管理,需关注CEAP分级C5或C6患者的支架内再狭窄风险。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate the safety and efficacy of endovascular treatment for post-thrombotic syndrome (PTS) in the lower extremities, and to identify risk factors contributing to in-stent restenosis. METHODS: Patients with PTS who underwent endovascular treatment at our institution from May 2016 to April 2022 were included in this study. Clinical symptoms were systematically assessed using the Villalta score, the Clinical, Etiological, Anatomical, and Pathophysiological (CEAP) classification, and the Venous Clinical Severity Score. Primary and secondary patency rates were assessed by duplex ultrasound examination. Risk factors associated with in-stent restenosis were analyzed using univariate and multivariate Cox regression models. A repeated measures analysis of variance was conducted to compare clinical symptom scores before and after treatment. RESULTS: A total of 115 patients were included in the study. The median follow-up duration was 48 months (range, 24-65 months). The primary patency rates at 3 months, 6 months, 1 year, 2 years, 3 years, and 4 years were 92.2% ± 2.5%, 88.7% ± 3.0%, 81.7% ± 3.6%, 73.9% ± 4.1%, 66.6% ± 4.5%, and 65.3% ± 4.6%, respectively. Stent restenosis was observed in 38 patients. At 1 year postoperatively, the Venous Clinical Severity Score exhibited a significant reduction of 7.0 (95% confidence interval [CI]. 6.0-8.0; P < .001) relative to preoperative levels. The Villalta score demonstrated a significant decrease of 11.4 (95% CI, 9.4-13.5; P < .001) compared with preoperative levels. Cox regression analysis indicated that a CEAP classification of C5 or C6 (hazard ratio, 2.24; 95% CI, 1.18-4.25; P = .014) was associated with stent restenosis. CONCLUSIONS: Endovascular treatment, with favorable long-term patency rates, is a safe and effective approach for managing PTS. CEAP classification of C5 or C6 has been identified as a risk factor for stent restenosis.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Zhang L, Song W, Chen Z, et al. Four-year outcomes following endovascular treatment in patients with post-thrombotic syndrome of the lower extremities. J Vasc Surg Venous Lymphat Disord. 2025. PMID: 40379212. doi:10.1016/j.jvsv.2025.102260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。